Yes, a 5 mm depth of invasion in cutaneous squamous cell carcinoma is definitively considered high-risk.
A tumor with 5 mm depth of invasion meets the threshold for high-risk cSCC and warrants aggressive management with Mohs micrographic surgery (MMS) as the preferred treatment modality.
Risk Stratification Based on Depth
While the American Academy of Dermatology guidelines 11111 do not explicitly define a specific depth cutoff in the provided excerpts, multiple research studies consistently identify depth thresholds for high-risk disease:
- Depth >2 mm is widely recognized as a high-risk feature 234
- Your tumor at 5 mm depth substantially exceeds this threshold, placing it firmly in the high-risk category
- The European consensus guidelines specifically note that tumors with histological thickness >6 mm warrant extended 10 mm surgical margins 4, and your 5 mm tumor approaches this threshold
Clinical Implications of 5 mm Depth
Increased risk profile includes:
- Significantly elevated metastatic potential - depth of invasion is a strong predictor of metastasis 35
- Higher local recurrence rates - tumor depth correlates with recurrence risk 5
- Greater mortality risk - deeper tumors are associated with worse survival outcomes 5
Treatment Recommendations
MMS is recommended for high-risk cSCC 111, and your 5 mm depth tumor qualifies. The guidelines explicitly state: "MMS is recommended for high-risk cSCC" and "strong caution is advised when selecting a treatment modality for high-risk tumors without a complete margin assessment" 11.
If MMS is not available or feasible:
- Standard excision requires wider margins than the 4-6 mm used for low-risk tumors
- Consider 10 mm margins based on European guidelines for tumors >6 mm thickness 4
- Delay complex reconstruction until negative margins are confirmed 1
Additional Workup Required
Given the 5 mm depth, you should:
- Perform lymph node ultrasound - particularly important for high-risk features 4
- Consider imaging (CT/MRI) if there are signs of underlying structure involvement 4
- Evaluate for other high-risk features: perineural invasion, poor differentiation, immunosuppression status 23
Follow-up Considerations
Close surveillance is mandatory for tumors with this depth:
- The combination of depth >2 mm with other high-risk features may warrant consideration of adjuvant therapy discussions 6
- Recent evidence supports adjuvant cemiplimab for high-risk disease with significantly improved disease-free survival 6
Critical Pitfall to Avoid
Do not treat a 5 mm depth tumor as low-risk. The guidelines clearly distinguish that high-risk tumors require different management approaches, and depth >2 mm is consistently cited as a high-risk feature across multiple authoritative sources 234. Standard excision with 4-6 mm margins appropriate for low-risk tumors would be inadequate for your patient's tumor.